ACM

ADAR1 Capital Management Portfolio holdings

AUM $1.01B
1-Year Est. Return 174.02%
This Quarter Est. Return
1 Year Est. Return
+174.02%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.01B
AUM Growth
+$394M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
251
New
Increased
Reduced
Closed

Top Buys

1
+$27.5M
2
+$21.3M
3
+$21.3M
4
ETNB
89bio
ETNB
+$18.2M
5
LXEO icon
Lexeo Therapeutics
LXEO
+$9.21M

Top Sells

1
+$146M
2
+$18.6M
3
+$11M
4
MLYS icon
Mineralys Therapeutics
MLYS
+$8.49M
5
RAPT icon
RAPT Therapeutics
RAPT
+$7.1M

Sector Composition

1 Healthcare 87.56%
2 Financials 1.74%
3 Consumer Discretionary 0.24%
4 Communication Services 0.1%
5 Technology 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARDX icon
201
Ardelyx
ARDX
$1.35B
– –
-915,130
ARGX icon
202
argenx
ARGX
$56.4B
– –
-1,759
AUPH icon
203
Aurinia Pharmaceuticals
AUPH
$2.1B
– –
-10,000
AVXL icon
204
Anavex Life Sciences
AVXL
$328M
– –
-16,221
BCAB icon
205
BioAtla
BCAB
$45.8M
– –
-170,506
BOLT icon
206
Bolt Biotherapeutics
BOLT
$9.6M
– –
-10,823
BPMC
207
DELISTED
Blueprint Medicines
BPMC
– –
-15,000
CASI icon
208
CASI Pharmaceuticals
CASI
$19.1M
– –
-44,120
CLBR
209
DELISTED
Colombier Acquisition Corp II
CLBR
– –
-10,000
CNTB
210
Connect Biopharma Holdings
CNTB
$149M
– –
-10,300
CRMD icon
211
CorMedix
CRMD
$771M
– –
-175,000
DSGN icon
212
Design Therapeutics
DSGN
$509M
– –
-42,408
ELDN icon
213
Eledon Pharmaceuticals
ELDN
$111M
– –
-16,900
EMCGR
214
DELISTED
Embrace Change Acquisition Corp Rights
EMCGR
– –
-13,144
EMCGW
215
DELISTED
Embrace Change Acquisition Corp Warrants
EMCGW
– –
-18,000
ENGN icon
216
enGene Holdings
ENGN
$526M
– –
-27,787
EPIX
217
DELISTED
ESSA Pharma
EPIX
– –
-50,000
INMB icon
218
INmune Bio
INMB
$41.7M
– –
0
INZY
219
DELISTED
Inozyme Pharma
INZY
– –
-37,161
IOVA icon
220
Iovance Biotherapeutics
IOVA
$846M
– –
0
ITOS
221
DELISTED
iTeos Therapeutics
ITOS
– –
-26,937
KVAC icon
222
Keen Vision Acquisition Corp
KVAC
$108M
– –
-75,000
KVACW icon
223
Keen Vision Acquisition Corp Warrant
KVACW
$879K
– –
-75,000
KYMR icon
224
Kymera Therapeutics
KYMR
$4.62B
– –
-13,366
MOVE icon
225
Movano
MOVE
$7.68M
– –
-1,915
6 7 8
9
10